Immediate Impact

50 standout
Sub-graph 1 of 23

Citing Papers

Novel strategies to manage CAR-T cell toxicity
2025 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
3 intermediate papers

Works of Patrick B. Johnston being referenced

Lisocabtagene Maraleucel (liso-cel) Versus Standard of Care (SOC) with Salvage Chemotherapy Followed By Autologous Stem Cell Transplantation (ASCT) As Second-Line (2L) Treatment in Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL): Primary Analysis of the Randomized, Phase 3 Transform Study
2022
Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study
2014

Author Peers

Author Last Decade Papers Cites
Patrick B. Johnston 271 385 51 193 12 444
JH van Krieken 240 368 60 222 7 458
Stephen M. Ansell 303 294 61 145 10 420
K. Adams 256 323 79 133 8 512
WG Sanger 201 339 60 184 8 389
J. Kaitlin Morrison 226 252 37 132 17 374
Junji Hiraga 181 256 98 137 17 447
Ulrich von Gruenhagen 262 413 44 285 11 450
M E Williams 241 322 58 189 8 428
Manuel F. Rosado 244 328 85 96 14 483
Simon Rule 238 314 31 186 12 383

All Works

Loading papers...

Rankless by CCL
2026